tiprankstipranks
Trending News
More News >
Teladoc Inc. (DE:4LL)
:4LL
Germany Market
Advertisement

Teladoc (4LL) Stock Forecast & Price Target

Compare
9 Followers
See the Price Targets and Ratings of:

4LL Analyst Ratings

Hold
12Ratings
Hold
3 Buy
9 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Teladoc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

4LL Stock 12 Month Forecast

Average Price Target

€8.38
▲(24.64% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Teladoc in the last 3 months. The average price target is €8.38 with a high forecast of €10.37 and a low forecast of €6.91. The average price target represents a 24.64% change from the last price of €6.72.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"€5","12":"€12","6.75":"€6.75","8.5":"€8.5","10.25":"€10.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10.3722066,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€10.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.3755568295,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€8.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.9148044,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€6.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,6.75,8.5,10.25,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.63,6.9178620461538465,7.205724092307692,7.493586138461539,7.7814481846153845,8.069310230769231,8.357172276923077,8.645034323076924,8.93289636923077,9.220758415384616,9.508620461538461,9.796482507692307,10.084344553846154,{"y":10.3722066,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.63,6.764273602269231,6.8985472045384615,7.032820806807693,7.167094409076923,7.301368011346154,7.435641613615385,7.569915215884616,7.704188818153846,7.8384624204230775,7.972736022692308,8.107009624961538,8.24128322723077,{"y":8.3755568295,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.63,6.65190803076923,6.673816061538462,6.695724092307692,6.717632123076923,6.739540153846154,6.761448184615385,6.783356215384615,6.805264246153846,6.827172276923077,6.849080307692308,6.8709883384615384,6.89289636923077,{"y":6.9148044,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.109,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.529,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.09,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.959,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.036,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.107,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.16,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.397,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.001,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.229,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.623,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.63,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€10.37Average Price Target€8.38Lowest Price Target€6.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:4LL
Canaccord Genuity
Canaccord Genuity
€10.31
Buy
53.43%
Upside
Reiterated
10/31/25
Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Wave Life Sciences (WVE)
TR | OpenAI - 4o Analyst forecast on DE:4LL
TR | OpenAI - 4o
TR | OpenAI - 4o
€7.3€7.73
Hold
15.07%
Upside
Reiterated
10/31/25
AI Generated ArticleAI Generated Article
Bank of America Securities Analyst forecast on DE:4LL
Bank of America Securities
Bank of America Securities
€7.73
Hold
15.07%
Upside
Reiterated
10/30/25
Teladoc's Strategic Acquisitions Show Promise Amid Competitive Challenges: Hold Rating Justified
Needham
Hold
Reiterated
10/30/25
Teladoc's Strategic Investments and Growth Uncertainty Lead to Hold Rating Amid CFO Transition
Evercore ISI
€7.73€6.87
Hold
2.28%
Upside
Reiterated
10/30/25
Evercore ISI Keeps Their Hold Rating on Teladoc (TDOC)
Truist Financial Analyst forecast on DE:4LL
Truist Financial
Truist Financial
Hold
Reiterated
10/30/25
Truist Financial Sticks to Its Hold Rating for Teladoc (TDOC)
William Blair Analyst forecast on DE:4LL
William Blair
William Blair
Hold
Reiterated
10/29/25
Teladoc's Transitional Phase: Hold Rating Amidst Strategic and Financial ChallengesWednesday, October 29, 2025 9:06 PM William Blair Equity Research | Healthcare Teladoc Health, Inc.
Wells Fargo Analyst forecast on DE:4LL
Wells Fargo
Wells Fargo
€6.87
Hold
2.28%
Upside
Reiterated
10/29/25
Wells Fargo Sticks to Its Hold Rating for Teladoc (TDOC)
J.P. Morgan Analyst forecast on DE:4LL
J.P. Morgan
J.P. Morgan
Hold
Reiterated
10/24/25
J.P. Morgan Sticks to Its Hold Rating for Teladoc (TDOC)
TD Cowen
€6.87
Hold
2.28%
Upside
Reiterated
10/24/25
TD Cowen Sticks to Its Hold Rating for Teladoc (TDOC)
Piper Sandler Analyst forecast on DE:4LL
Piper Sandler
Piper Sandler
€10.31
Buy
53.43%
Upside
Reiterated
10/23/25
Teladoc (TDOC) Gets a Buy from Piper Sandler
Citi
€8.16€9.02
Hold
34.25%
Upside
Reiterated
10/21/25
Teladoc price target raised to $10.50 from $9.50 at CitiTeladoc price target raised to $10.50 from $9.50 at Citi
Goldman Sachs Analyst forecast on DE:4LL
Goldman Sachs
Goldman Sachs
€8.59
Buy
27.86%
Upside
Reiterated
08/13/25
Stifel Nicolaus Analyst forecast on DE:4LL
Stifel Nicolaus
Stifel Nicolaus
€6.87
Hold
2.28%
Upside
Reiterated
07/30/25
Stifel Nicolaus Sticks to Its Hold Rating for Teladoc (TDOC)
Leerink Partners Analyst forecast on DE:4LL
Leerink Partners
Leerink Partners
€6.44
Hold
-4.11%
Downside
Reiterated
07/30/25
Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:4LL
Canaccord Genuity
Canaccord Genuity
€10.31
Buy
53.43%
Upside
Reiterated
10/31/25
Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Wave Life Sciences (WVE)
TR | OpenAI - 4o Analyst forecast on DE:4LL
TR | OpenAI - 4o
TR | OpenAI - 4o
€7.3€7.73
Hold
15.07%
Upside
Reiterated
10/31/25
AI Generated ArticleAI Generated Article
Bank of America Securities Analyst forecast on DE:4LL
Bank of America Securities
Bank of America Securities
€7.73
Hold
15.07%
Upside
Reiterated
10/30/25
Teladoc's Strategic Acquisitions Show Promise Amid Competitive Challenges: Hold Rating Justified
Needham
Hold
Reiterated
10/30/25
Teladoc's Strategic Investments and Growth Uncertainty Lead to Hold Rating Amid CFO Transition
Evercore ISI
€7.73€6.87
Hold
2.28%
Upside
Reiterated
10/30/25
Evercore ISI Keeps Their Hold Rating on Teladoc (TDOC)
Truist Financial Analyst forecast on DE:4LL
Truist Financial
Truist Financial
Hold
Reiterated
10/30/25
Truist Financial Sticks to Its Hold Rating for Teladoc (TDOC)
William Blair Analyst forecast on DE:4LL
William Blair
William Blair
Hold
Reiterated
10/29/25
Teladoc's Transitional Phase: Hold Rating Amidst Strategic and Financial ChallengesWednesday, October 29, 2025 9:06 PM William Blair Equity Research | Healthcare Teladoc Health, Inc.
Wells Fargo Analyst forecast on DE:4LL
Wells Fargo
Wells Fargo
€6.87
Hold
2.28%
Upside
Reiterated
10/29/25
Wells Fargo Sticks to Its Hold Rating for Teladoc (TDOC)
J.P. Morgan Analyst forecast on DE:4LL
J.P. Morgan
J.P. Morgan
Hold
Reiterated
10/24/25
J.P. Morgan Sticks to Its Hold Rating for Teladoc (TDOC)
TD Cowen
€6.87
Hold
2.28%
Upside
Reiterated
10/24/25
TD Cowen Sticks to Its Hold Rating for Teladoc (TDOC)
Piper Sandler Analyst forecast on DE:4LL
Piper Sandler
Piper Sandler
€10.31
Buy
53.43%
Upside
Reiterated
10/23/25
Teladoc (TDOC) Gets a Buy from Piper Sandler
Citi
€8.16€9.02
Hold
34.25%
Upside
Reiterated
10/21/25
Teladoc price target raised to $10.50 from $9.50 at CitiTeladoc price target raised to $10.50 from $9.50 at Citi
Goldman Sachs Analyst forecast on DE:4LL
Goldman Sachs
Goldman Sachs
€8.59
Buy
27.86%
Upside
Reiterated
08/13/25
Stifel Nicolaus Analyst forecast on DE:4LL
Stifel Nicolaus
Stifel Nicolaus
€6.87
Hold
2.28%
Upside
Reiterated
07/30/25
Stifel Nicolaus Sticks to Its Hold Rating for Teladoc (TDOC)
Leerink Partners Analyst forecast on DE:4LL
Leerink Partners
Leerink Partners
€6.44
Hold
-4.11%
Downside
Reiterated
07/30/25
Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Teladoc

1 Month
xxx
Success Rate
19/42 ratings generated profit
45%
Average Return
-3.19%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 45.24% of your transactions generating a profit, with an average return of -3.19% per trade.
3 Months
xxx
Success Rate
26/48 ratings generated profit
54%
Average Return
+2.01%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.17% of your transactions generating a profit, with an average return of +2.01% per trade.
1 Year
Richard CloseCanaccord Genuity
Success Rate
24/49 ratings generated profit
49%
Average Return
+18.17%
reiterated a buy rating 9 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 48.98% of your transactions generating a profit, with an average return of +18.17% per trade.
2 Years
xxx
Success Rate
21/48 ratings generated profit
44%
Average Return
+48.28%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 43.75% of your transactions generating a profit, with an average return of +48.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

4LL Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
2
0
0
0
0
Buy
0
2
3
3
4
Hold
25
40
27
31
31
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
42
30
34
35
In the current month, 4LL has received 4 Buy Ratings, 31 Hold Ratings, and 0 Sell Ratings. 4LL average Analyst price target in the past 3 months is 8.38.
Each month's total comprises the sum of three months' worth of ratings.

4LL Financial Forecast

4LL Earnings Forecast

Next quarter’s earnings estimate for 4LL is -€0.15 with a range of -€0.22 to -€0.05. The previous quarter’s EPS was -€0.24. 4LL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 4LL has Preformed in-line its overall industry.
Next quarter’s earnings estimate for 4LL is -€0.15 with a range of -€0.22 to -€0.05. The previous quarter’s EPS was -€0.24. 4LL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 4LL has Preformed in-line its overall industry.

4LL Sales Forecast

Next quarter’s sales forecast for 4LL is €549.87M with a range of €543.89M to €554.88M. The previous quarter’s sales results were €542.88M. 4LL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 4LL has Preformed in-line its overall industry.
Next quarter’s sales forecast for 4LL is €549.87M with a range of €543.89M to €554.88M. The previous quarter’s sales results were €542.88M. 4LL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 4LL has Preformed in-line its overall industry.

4LL Stock Forecast FAQ

What is DE:4LL’s average 12-month price target, according to analysts?
Based on analyst ratings, Teladoc Inc.’s 12-month average price target is 8.38.
    What is DE:4LL’s upside potential, based on the analysts’ average price target?
    Teladoc Inc. has 24.64% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Teladoc Inc. a Buy, Sell or Hold?
          Teladoc Inc. has a consensus rating of Hold, which is based on 3 buy ratings, 9 hold ratings and 0 sell ratings.
            What is Teladoc Inc.’s share price target?
            The average share price target for Teladoc Inc. is 8.38. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €10.37 ,and the lowest forecast is €6.91. The average share price target represents 24.64% Increase from the current price of €6.72.
              What do analysts say about Teladoc Inc.?
              Teladoc Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Teladoc Inc.?
                To buy shares of DE:4LL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis